SOX2 and breast carcinoma: For example, in a study of breast cancer patients, SOX2 was strongly detected by immunohistochemistry in the nucleus of breast carcinoma cells compared to weak or no SOX2 staining in normal, non-tumorigenic mammary epithelial issue [20, 33].